Danial Saifuddin

Dr. Danial Saifuddin is an Associate Lecturer at the School of Pharmacy and Pharmaceutical Sciences, The University of Queensland. His research focuses on opioid peptides, drug delivery systems, and inflammatory disease therapeutics. He has contributed to studies on bivalent opioid constructs targeting pain and opioid use disorder, with a particular emphasis on peripheral receptor interactions and metabolic stability optimization.

His work spans conferences such as the FIP World Congress and ASCEPT/APFP/APSA Joint Conference, where he presented advancements in peptide design and receptor targeting. Dr. Saifuddin’s 2025 book chapter explores polyphenolic nanoformulations for psoriasis treatment, highlighting his interdisciplinary approach to pharmaceutical sciences. His academic contributions include a PhD thesis titled Bivalent Opioid Constructs as Allosteric Modulators of Nociception (2024).

While no formal awards are listed, his active participation in research projects like the Optimising Medicine Information Handover After Discharge (OPTMED-D) and Safe and Effective Medication Collaborative underscores his commitment to translational research and clinical impact.